AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 292: H549-H559, 2007. First published August 25, 2006; doi:10.1152/ajpheart.00701.2006
0363-6135/07 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/H549    most recent
00701.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seemann, G.
Right arrow Articles by Tristani-Firouzi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seemann, G.
Right arrow Articles by Tristani-Firouzi, M.

Modeling of IK1 mutations in human left ventricular myocytes and tissue

Gunnar Seemann,1 Frank B. Sachse,2,3 Daniel L. Weiss,1 Louis J. Ptácek,4 and Martin Tristani-Firouzi2,5

1Institut für Biomedizinische Technik, Universität Karlsruhe (TH), Karlsruhe, Germany; 2Nora Eccles Harrison Cardiovascular Research and Training Institute and 3Bioengineering Department, University of Utah, Salt Lake City, Utah; 4Howard Hughes Medical Institute, Department of Neurology, University of California, San Francisco, California; and 5Division of Pediatric Cardiology, University of Utah, Salt Lake City, Utah

Submitted 30 June 2006 ; accepted in final form 22 August 2006


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Elucidation of the cellular basis of arrhythmias in ion channelopathy disorders is complicated by the inherent difficulties in studying human cardiac tissue. Thus we used a computer modeling approach to study the mechanisms of cellular dysfunction induced by mutations in inward rectifier potassium channel (Kir)2.1 that cause Andersen-Tawil syndrome (ATS). ATS is an autosomal dominant disorder associated with ventricular arrhythmias that uncommonly degenerate into the lethal arrhythmia torsade de pointes. We simulated the cellular and tissue effects of a potent disease-causing mutation D71V Kir2.1 with mathematical models of human ventricular myocytes and a bidomain model of transmural conduction. The D71V Kir2.1 mutation caused significant action potential duration prolongation in subendocardial, midmyocardial, and subepicardial myocytes but did not significantly increase transmural dispersion of repolarization. Simulations of the D71V mutation at shorter cycle lengths induced stable action potential alternans in midmyocardial, but not subendocardial or subepicardial cells. The action potential alternans was manifested as an abbreviated QRS complex in the transmural ECG, the result of action potential propagation failure in the midmyocardial tissue. In addition, our simulations of D71V mutation recapitulate several key ECG features of ATS, including QT prolongation, T-wave flattening, and QRS widening. Thus our modeling approach faithfully recapitulates several features of ATS and provides a mechanistic explanation for the low frequency of torsade de pointes arrhythmia in ATS.

Andersen-Tawil syndrome; Kir2.1 mutation; ion channel modeling


THE INWARD RECTIFIER potassium current IK1 is the major determinant of the resting membrane potential in the heart and participates in the most terminal phase of action potential repolarization (10). IK1 is conducted by homo- and/or heterotetrameric channels formed by coassembly of the inward rectifier potassium channel (Kir)2.x subfamily of proteins (Kir2.1, Kir2.2, and Kir2.3). Message and protein expression studies indicate that Kir2.1 is the most abundant subfamily member in ventricular tissue (19, 23). Mutations in KCNJ2, the gene encoding Kir2.1, cause Andersen-Tawil syndrome (ATS), an autosomal dominant disorder associated with ventricular arrhythmias, periodic skeletal muscle paralysis, and dysmorphic skeletal features (7). ATS is a disorder of ventricular repolarization that is manifested by mild QTc interval prolongation but marked prolongation of the QUc interval (15, 22). Prominent U waves are a frequent finding in this disorder. Arrhythmias in ATS patients include frequent premature ventricular contractions, bigeminy, and nonsustained polymorphic and bidirectional ventricular tachycardia (15). Although tachycardia burden is often high in ATS subjects (2), degeneration into lethal ventricular arrhythmias is relatively uncommon (17).

The vast majority of KCNJ2 mutations cause loss of function when expressed alone and variable degrees of dominant-negative suppression of wild-type (WT) Kir2.1 channel function (1, 15). Disease-causing mutant Kir2.1 subunits also exert dominant-negative effects on Kir2.2 and -2.3 channel function (8). One mutant, D71V Kir2.1, exerts a strong dominant-negative effect on all Kir2.x family members, consistent with the idea that one or more mutant subunits within the tetrameric complex are sufficient to eliminate channel function (7). Thus the functional current is carried only through tetramers containing four WT subunits representing 1/16 (6.25%) of control values. Recently, in vivo adenoviral gene transfer of a dominant-negative Kir2.1 construct in guinea pig left ventricle induced a variable cellular phenotype depending on the degree of IK1 suppression (5, 6). Action potential duration (APD) prolongation was noted in isolated cardiomyocytes with moderate degrees of IK1 suppression. More severe IK1 suppression resulted in spontaneous electrical activity, the so-called genetically engineered "biological pacemaker."

The ionic mechanisms underlying biological pacemaker activity have been reported with computational models of guinea pig and human ventricular myocytes. With the Luo-Rudy guinea pig ventricle model, stable spontaneous pacemaker activity developed in the setting of reduced IK1 conductance (gK1) to 19% of control values (12). The primary pacemaker current was conducted by the Na+/Ca2+ exchanger (INaCa). Using a modified Priebe-Beuckelmann model of human ventricle, Kurata and colleagues (3) reported that spontaneous activity developed at 15% gK1 and that INaCa was critical for spontaneous electrical activity. However, they reported that the major role for INaCa in the maintenance of stable pacemaker activity was not simply as a depolarizing current during phase 4, but rather maintaining low intracellular Ca2+ concentration to prevent Ca2+-dependent inactivation of L-type Ca2+ current.

Rather than focusing on the ionic mechanisms of biological pacemaker activity, we were interested in the mechanisms of cellular dysfunction induced by ATS mutations in Kir2.1. We used an electrophysiological model of human ventricular myocytes (ten Tusscher et al., Ref. 14) to simulate the cellular effects of reduced IK1 caused by a potent dominant-negative mutant, D71V Kir2.1. The myocyte model includes all major ionic currents and is based on data from human ventricular myocytes or expression of human cardiac ion channels. Our modification of the model incorporates electrophysiological data from multiple myocyte types across the ventricular wall, allowing for the reconstruction of transmural heterogeneity in the left ventricle. We applied a bidomain approach of electrical conduction to calculate transmural ECGs. Thus the objective of this study was to determine the electrophysiological consequences of a Kir2.1 diseasing-causing mutation at the cellular and tissue levels.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Modeling of IK1 channels. The inwardly rectifying potassium current IK1 is controlled by tetrameric ion channels formed by coassembly of the Kir2.x subfamily of proteins. We assume that the probability of subunit combinations underlying an individual ion channel can be approximated by multinomial distributions. The probability (P) of a subunit combination (X1,..., Xk) is given by the multinomial distribution:

Formula 1(1)
with the nonnegative integers x1,...,xk, single subunit probabilities p1,...,pk, the number of subunits of a channel

Formula 1
and the number of subunit types k. IK1 channels are tetrameric; thus n = 4. The single-subunit probabilities pi are constants. These probabilities are measurable by studies of protein densities and dependent on tissue type and species.

The current IK1 through an ensemble of channels can be defined as:

Formula 2(2)
with the number of channels in the ensemble N and the current Formula 2, which is for a specific subunit combination.

Simplifications of Eq. 1 can be applied to characterize IK1 and reconstruct measurement results from electrophysiological studies. For example, in the case of only two subunit types, the probability for a subunit combination (x1,x2) can be described with a binomial distribution:

Formula 3(3)
A simplification of Eq. 2 results from properties of dominant-negative mutations in subunit combinations. Here, only mutation-free combinations allow current flow through channels, i.e., Formula 3 for combinations with mutated subunits.

Myocyte and tissue modeling. An electrophysiological model of human left ventricular subepicardial myocytes (ten Tusscher et al., Ref. 14) was used to reconstruct the cellular electrophysiological properties. The model is based on coupled nonlinear first-order ordinary differential equations, which describe ion concentrations, fluxes through dynamically changing ion channels, pumps, and exchangers, as well as the transmembrane voltage (Vm). This model was adapted similarly as described previously to reconstruct transmural heterogeneity (11). In short, the rapidly activating, voltage-gated potassium current Ito and the slowly activating, delayed potassium current IKs were modeled as a function of left ventricular free wall location. The conductance gto is changing over space as described originally by ten Tusscher et al. (14), and gKs is varying equivalent to the approach used in Ref. 11. Myocyte models were created for various wall locations (e.g., subendocardial, midmyocardial, and subepicardial) and different descriptions of IK1 channels, applying Eqs. 1 and 2. Simulations with the cell models were carried out with the Euler method for numerical integration of ordinary differential equations and a time step of 10 µs (9). Results after the 100th stimulation were analyzed for each simulation.

A strand model of the left ventricular free wall was created based on a bidomain approach to reconstructing anisotropic electrical conduction (20). The bidomain model allowed for calculation of current flow through gap junctions and the intracellular space as well as through the extracellular space. The current flow was reconstructed with Poisson's equation for both intra- and extracellular domains for stationary electrical fields. An iterative Gauss-Seidel method with a time step of 10 µs was applied to solve the system of partial differential equations with the finite differences method (9). The strand model was inserted virtually into a bath medium in which two electrode positions were selected to extract the transmural ECG during electrophysiological activity (Fig. 1A). Electrophysiological heterogeneity in the strand was reconstructed by wall location-specific assignment of the myocyte models. The midmyocardial region was located at 20% of the distance from endocardium to epicardium, thus in the deep subendocardium. The orientation of muscle fibers leading to the anisotropic conduction was inserted into the model in such a way that the depolarization propagated always transverse to the fibers. Propagation was initiated by injecting an appropriate electrical current into the intracellular domain of cells at the endocardial end of the strand. This reconstructs the activation of the tissue due to the Purkinje fiber network. Figure 1B displays a normal excitation and repolarization process given by this model at different time instances. Data after the 10th stimulation were used for analyzing the simulations.


Figure 1
View larger version (67K):
[in this window]
[in a new window]

 
Fig. 1. Transmural strand model for the calculation of excitation propagation. A: the heterogeneous strand model with the excitable tissue in blue is inserted in a bath (turquoise). The positions for measurement of the transmural ECG are marked with red circles. B: excitation propagation and repolarization at different times for the physiological model. Excitation was initiated at the subendocardium representing Purkinje fiber activation. The depolarization is conducted toward subepicardium. Repolarization propagates from subepicardium toward subendocardium.

 

    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Estimation of functional IK1 induced by D71V mutation. ATS is an autosomal dominant disorder, and therefore affected individuals express 50% mutant and 50% WT Kir2.1 protein. Assuming random association of mutant and WT subunits, the combinatorial possibilities of tetrameric channels are described by a binomial distribution (Eq. 3). The probability of a homomeric WT channel is 6.25%. We elected to study the dominant-negative ATS mutant D71V given that coexpression experiments indicated that functional current was conducted only by WT homomeric channels. Cardiac IK1 is conducted by the sum of Kir2.1, -2.2, and -2.3 channels. From mRNA expression in human ventricle, Kir2.1 subunits constitute 92% of total Kir2.x, with Kir2.2 and -2.3 contributing 7% and 1%, respectively (Table 1). Four distinct subunit types (i.e., WT Kir2.1, D71V Kir2.1, Kir2.2, and Kir2.3) were considered for the calculation of subunit combinations. Using Eq. 1, we estimated that the probability of homomeric channels consisting of only WT Kir2.1, -2.2, or -2.3 subunits is 8.5%. In the simulations that follow, we use 8.5% gK1 as an estimate of the effect of D71V on total ventricular IK1. Further simulations with 20% gK1 serve for prediction of the effects of Kir2.1 mutations that cause less severe degrees of dominant-negative suppression of IK1 (15).


View this table:
[in this window]
[in a new window]

 
Table 1. Absolute and relative mRNA levels in human cardiac tissue

 
Effect of gK1 reduction in single ventricular myocytes. Simulated Vm for subendocardial, midmyocardial, and subepicardial human left ventricular myocytes in response to pacing frequencies of 1 and 2 Hz are demonstrated in Fig. 2. The APD of the midmyocardial cell was longer than that of subendocardial and subepicardial cells, an effect attributable to the relative decrease in IKs density in midmyocardium (21) (Table 2 and Fig. 2). A progressive reduction in gK1 resulted in a progressive decrease in resting Vm in all three cell layers (Table 2), consistent with the role of this current in setting diastolic Vm. Decreasing gK1 to 20% of control values caused APD prolongation for all three cell types; however, the degree of APD prolongation was greater in midmyocardial cells compared with subendocardial and subepicardial cells (Table 2 and Fig. 2). A further reduction in gK1 to 8.5% of control values caused a modest amount of additional APD prolongation compared with 20% gK1, but produced a reduction of the maximal diastolic Vm and in the phase 1 notch. Increasing the pacing frequency to 2 Hz did not markedly alter the action potential parameters in the setting of reduced gK1 (Table 2 and Fig. 2).


Figure 2
View larger version (17K):
[in this window]
[in a new window]

 
Fig. 2. Transmembrane voltages (Vm) of subendocardial (A, B), midwall (C, D), and subepicardial (E, F) myocytes for stimulation frequencies of 1 (A, C, E) and 2 (B, D, F) Hz and 8.5%, 20%, and 100% inward rectifier potassium current (IK1) conductance (gK1). The stimulus was applied at t = 50 ms. Reduction of gK1 led to increased action potential durations (APDs) and depolarized resting voltages.

 

View this table:
[in this window]
[in a new window]

 
Table 2. Diastolic transmembrane voltage and action potential duration at different levels of gK1 in the three cell types at different frequencies

 
The effects of reduced gK1 on transmembrane currents in a subendocardial myocyte during 1-Hz stimulation are demonstrated in Fig. 3. The peak amplitude of sodium current (INa) and Ito progressively decreased as gK1 decreased (Fig. 3B), accounting for the reduced maximal diastolic Vm and reduced phase 1 notch in simulated action potentials (Fig. 2). Rapidly activating delayed rectifier potassium current (IKr) is increased substantially and to a greater degree than IKs in the setting of reduced gK1 (Fig. 3, C and D) and provided the majority of repolarizing current during phase 3. L-type calcium current (ICa) was essentially unaffected by reduced gK1. Decreasing gK1 to 20% and 8.5% of control values decreased the amplitude of INaCa during phases 1, 3, and 4.


Figure 3
View larger version (15K):
[in this window]
[in a new window]

 
Fig. 3. Transmembrane currents of subendocardial myocyte paced at 1 Hz for 100%, 20%, and 8.5% gK1 with IK1 (A); rapidly activating, voltage-gated potassium current (Ito; B); rapidly activating delayed rectifier potassium current (IKr; C); slowly activating, delayed potassium current (IKs; D); L-type calcium current (ICa; E); Na+/Ca2+ exchanger (INaCa; F); and sodium current (INa; G).

 
A further increase in pacing frequency to 3 Hz in the setting of reduced gK1 caused significant perturbations in action potential parameters from all cell types (Fig. 4). Subendocardial and subepicardial cells behaved similarly, with 20% gK1 causing a reduced phase 1 notch and 8.5% gK1 causing marked slowing of the action potential upstroke. The upstroke in the setting of 8.5% gK1 was mediated primarily by the stimulus current followed by ICa (Fig. 5E). The effect of increased pacing frequency was most dramatic in the midmyocardial cell, where a stable pattern of action potential alternans developed at 20% and 8.5% gK1 with marked abbreviation of action potential amplitude and duration. The transmembrane currents underlying action potential alternans at 3-Hz stimulation are presented in Fig. 5. Reduction of gK1 led to absence of INa and Ito (Fig. 5, D and G). Also, ICa was markedly reduced during the abbreviated action potential (Fig. 5E). The majority of repolarizing current during phases 2 and 3 of the abbreviated action potential was provided by IKr, with a smaller contribution of IKs (Fig. 5, C and D). INaCa was reduced in concomitant fashion during the abbreviated action potential.


Figure 4
View larger version (12K):
[in this window]
[in a new window]

 
Fig. 4. Transmembrane voltages of subendocardial (A), midmyocardial (B), and subepicardial (C) myocytes for stimulation frequency of 3 Hz. Alternans was elicited in midwall myocytes for reduced gK1.

 

Figure 5
View larger version (16K):
[in this window]
[in a new window]

 
Fig. 5. Transmembrane currents of midmyocardial myocyte paced at 3 Hz for 100%, 20%, and 8.5% gK1 with IK1 (A), Ito (B), IKr (C), IKs (D), ICa (E), INaCa (F), and INa (G).

 
To explore the role of reduced gK1 in triggering spontaneous activity, cells were stimulated at 1, 2, and 3 Hz in settings of 0% to 7% gK1 and Vm was recorded following a pause in pacing rate. This protocol assessed the capacity for spontaneous activity as might occur during a sinus pause (Table 3). No spontaneous activity was detected after a pause preceded by 1-, 2-, and 3-Hz stimulation for gK1 larger than a threshold value of 6%. However, for gK1 less than or equal to the threshold, spontaneous action potentials were triggered. Action potentials and the underlying transmembrane currents for gK1 values near the threshold for spontaneous activity are shown in Fig. 6. A pause after 3-Hz pacing induced a single spontaneous action potential after a delay of 1.48 s in the setting of 6% gK1. The dominant inward current during phase 4 depolarization was INaCa, which depolarized Vm to the threshold of ICa activation, responsible for phase 0 upstroke (Fig. 6, F and G). Further reductions in gK1 resulted in an increased frequency of spontaneous action potential generation (Table 3).


View this table:
[in this window]
[in a new window]

 
Table 3. Number of spontaneous beats in 10-s pause and delay of first beat

 

Figure 6
View larger version (15K):
[in this window]
[in a new window]

 
Fig. 6. Transmembrane voltage and currents of subendocardial myocyte paced with 6% and 7% gK1 after stimulation with 3 Hz with Vm (A), IK1 (B), Ito (C), IKr (D), IKs (E), ICa (F), INaCa (G), and INa (H). A spontaneous beat was triggered 1,483 ms after the last stimulus in the myocyte with 6% gK1.

 
Tissue electrophysiology-simulated ECGs. Electrical conduction and transmural ECGs were simulated within the transmural strand model (Fig. 1A). The depolarization and repolarization process in the case of 100% gK1 is depicted in Fig. 1B at different time instances for a stimulation frequency of 1 Hz. The depolarization propagated from subendocardium to subepicardium, leading to a positive QRS complex in the transmural ECG (Fig. 7A). The repolarization propagated in the opposite direction, and thus the T wave is also positive.


Figure 7
View larger version (11K):
[in this window]
[in a new window]

 
Fig. 7. Transmural ECGs for different gK1 and a stimulus frequency of 1 (A), 2 (B), and 3 (C) Hz. D: expanded view of QRS complex depicted in A showing prolongation of QRS duration at 8.5% gK1 for a stimulus frequency of 1 Hz.

 
Simulated transmural ECGs in the setting of reduced gK1 are compared with control values in Fig. 7. Both 20% and 8.5% gK1 caused flattening and widening of the T wave as well as QRS and QT prolongation, a consequence of APD prolongations at the cellular level (Figs. 2 and 4); 8.5% gK1 prolonged the QT duration to 387 ms for a stimulus frequency of 1 Hz, compared with 357 ms in control conditions. QRS prolongation from 31 ms for control to 36 ms for 8.5% gK1 was due to reduced Na channel availability as a consequence of reduced membrane repolarization (Fig. 7D). This leads to a reduction in conduction velocity in the strand model. Alternans in the transmural ECG was observed for reduced gK1 at a stimulus frequency of 3 Hz (Fig. 7C).

Vm for exemplary cells along the strand are presented in Figs. 8 and 9. Action potentials indicating propagation from the subendocardial to subepicardial end of the strand were observed for stimulus frequencies of 1 and 2 Hz for 100% and 8.5% gK1 (Fig. 8, A and B, and 9, A and B). However, at the higher stimulus frequency of 3 Hz, action potential propagation was blocked within the midmyocardium in the setting of 8.5% gK1 (Fig. 9C).


Figure 8
View larger version (10K):
[in this window]
[in a new window]

 
Fig. 8. Vm of subendocardial, midmyocardial, and subepicardial cells in the strand model for 100% gK1 and a stimulus frequency of 1 (A), 2 (B), and 3 (C) Hz.

 

Figure 9
View larger version (10K):
[in this window]
[in a new window]

 
Fig. 9. Vm of subendocardial, midmyocardial, and subepicardial cells inside the strand model for 8.5% gK1 and a stimulus frequency of 1 (A), 2 (B), and 3 (C) Hz.

 
Repolarization was similarly timed in the strand for normal and reduced gK1 in the case of 1- and 2-Hz stimulation (Figs. 8 and 9). Transmural temporal differences to 90% repolarization were 30, 30, and 32 ms for 100%, 20%, and 8.5% gK1, respectively, for a stimulation frequency of 1 Hz. Transmural dispersion of repolarization was reduced for a stimulus frequency of 3 Hz. Here, the temporal differences to 90% repolarization amounted to 4 and 7 ms for 100% and 20% gK1, respectively.

A remarkable T-wave inversion for 3 Hz is visible in Fig. 7C for 100% gK1. This inversion can be explained by the action potentials in the transmural strand illustrated in Fig. 8C. The subepicardial cell repolarized last, causing propagation of repolarization from subendocardium to subepicardium. This led to an inverse T wave, in contrast to simulations with 1-Hz stimulation shown in Figs. 7A and 8A.


    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Elucidation of the cellular basis of arrhythmias in ion channelopathy disorders is complicated by the inability to study isolated human ventricular myocytes from healthy subjects or those with inherited diseases. Thus the use of mathematical models of human ventricular tissue to simulate the effects of ion channel dysfunction at the cellular and tissue levels is of paramount importance. Moreover, studies of the cellular consequences of Kir2.1 mutations associated with ATS are complicated by the lack of specific Kir2.1 channel blockers, further underscoring the importance of computational modeling. To this end, we used a modified ten Tusscher et al. model of human ventricular myocytes and a bidomain model of electrical conduction to study the cellular and tissue effects of a potent disease-causing mutation, D71V Kir2.1.

The D71V mutant Kir2.1 subunit behaves in heterologous expression systems like a "poison pill" (7, 8). That is, one mutant subunit within the tetrameric channel complex is sufficient to render the channel nonfunctional. ATS is an autosomal dominant disorder, and therefore an affected individual expresses a WT and a mutant allele. Assuming a random likelihood of subunit association, the probability of a tetramer containing one or more D71V subunits is 15/16 (93.75%) and the probability of containing four WT Kir2.1 subunits is 1/16 (6.25%). Indeed, coexpression of WT and D71V Kir2.1 induced a current that was ~5% of control values, implying that functional current was conducted through channels consisting only of WT subunits. From the relative abundance of Kir2.x transcripts in human ventricle (19) and the dominant-negative properties of D71V, we calculated that homotetrameric Kir2.x channels constitute 8.5% of the total number of channels that comprise human IK1. This approximation is based on the assumption that Kir2.x protein levels mirror that of mRNA and that mutant mRNA and protein are as stable as WT. With these caveats, we simulated the electrophysiological consequences of a Kir2.1 disease-causing mutation in human left ventricular tissue.

Our simulations revealed that reduced gK1 exerted differential effects on APD. Although reduced gK1 caused APD prolongation in all three cell types, APD prolongation was greatest in the midmyocardial cell. However, the differential APD prolongation in midmyocardial cells was diminished when cells were coupled in a transmural fiber, such that no significant increase in transmural dispersion of repolarization was detected. These findings are consistent with those reported by Tsuboi and Antzelevitch (16), who used BaCl2 to suppress IK1 in the canine wedge preparation. Thus the low frequency of torsade de pointes arrhythmia in ATS patients may be a consequence of the lack of transmural dispersion of repolarization in the setting of reduced IK1, despite the fact that APD is prolonged. Interestingly, the contribution of IKr to phase 3 repolarization increased dramatically in the setting of reduced gK1. The consequences of this observation are that patients with ATS may be at a substantially increased risk of arrhythmias in the setting of reduced IKr associated with hypokalemia or the wide variety of medications known to block hERG channels.

The effects of reduced gK1 were more dramatic at faster pacing rates. A stimulation frequency of 3 Hz at 8.5% gK1 induced a stable pattern of action potential alternans in the midmyocardial cell, characterized by alternating action potentials of reduced peak amplitude and duration. The reduced peak amplitude and duration were a consequence of markedly reduced Ito and ICa. The APD alternans resulted in the failure of action potentials to propagate through the midmyocardial portion of the simulated ventricular strand. Such a unidirectional block might provide a substrate for reentrant tachycardia.

Our simulations of the D71V mutation were unable to recapitulate some of the cardinal ECG abnormalities described in ATS patients, that is, prominent U waves and QU interval prolongation (see Limitations). Notwithstanding this, the presented transmural ECGs reproduced several important ATS features, including QT prolongation, flattening of the T wave, and QRS prolongation. QT prolongation was a prominent feature in the initial cohort of ATS probands, representing the most highly affected individuals (15). Low-amplitude or inverted T waves were described in 19% of ATS patients (22). An example of low-amplitude T waves in a patient with the D71V mutation is shown in Fig. 10. Similar T-wave changes were reported by Tsuboi and Antzelevitch (16) in their canine wedge preparation model of ATS. Our simulations indicate that flattening and widening of the T wave occur as a consequence of APD prolongation at the cellular level. Conduction disorders were identified in 23% of ATS patients, with a bundle branch block pattern documented in 14% (22). The simulated D71V mutation resulted in a 16% increase in QRS duration in the one-dimensional transmural strand. We anticipate that this degree of prolongation would be maintained in a three-dimensional heart, consistent with the QRS prolongation seen in some ATS patients. Our simulations indicate that QRS prolongation is due to partial inactivation of INa as a consequence of depolarized Vm in the setting of reduced gK1.


Figure 10
View larger version (35K):
[in this window]
[in a new window]

 
Fig. 10. Einthoven III lead of patient with D71V mutation. Note the low-amplitude T wave.

 
Miake and colleagues (5, 6) used in vivo gene transfer of a dominant-negative Kir2.1 construct in guinea pig left ventricle and induced a cellular phenotype that varied with the degree of IK1 suppression. For moderate levels of IK1 suppression, APD prolongation was detected in isolated myocytes, similar to that seen in our simulations of 20% and 8.5% gK1. Spontaneous action potentials were detected when IK1 density in transfected myocytes was <0.4 pA/pF, corresponding to ~13% of control gK1 (6). Spontaneous pacemaker activity was elicited in the Luo-Rudy and Priebe-Beuckelmann models at 19% and 15% gK1, respectively (3, 12). With the ten Tusscher et al. model, spontaneous action potential generation required 6% gK1 and a pause preceded by 3-Hz pacing. Spontaneous action potential generation was found for smaller gK1 for stimulus frequencies of 1–3 Hz. The differences in gK1 necessary for simulated pacemaker activity are related to underlying differences in the ventricular models. The Luo-Rudy formalism is based on guinea pig experimental data and would be predicted to best recapitulate the in vivo gene transfer results. The Priebe-Beuckelmann human ventricle model is a modified version of the Luo-Rudy phase II model, but several ionic currents are based on animal, not human, data.

Although our simulated D71V mutation did not trigger spontaneous pacemaker activity, the model tissue was near the threshold for spontaneous activity. Perhaps other triggers or comodifiers tip the balance toward local changes in IK1 that trigger spontaneous generation of action potentials. Indeed, ATS patients alternate between sinus rhythm and ventricular arrhythmias throughout the day, implying that spontaneous activity is not incessant. We propose that the D71V-induced reduction in gK1 provides the substrate for arrhythmia by altering the balance between inward and outward currents during phase 4 such that INaCa reaches a threshold to trigger spontaneous action potentials. Additional factors, such as hypokalemia, could promote arrhythmia in ATS patients by further reducing IK1 and IKr [both dependent on the concentration of extracellular potassium ([K+]o)]. Our simulations indicate an increased contribution of IKr during phase 3 in the setting of reduced gK1. Thus ATS patients may be particularly susceptible to changes in IKr (such as hERG channel blockers or decreased [K+]o) given the baseline reduced repolarization reserve and the dependence on IKr as a substitute for reduced IK1.

Limitations. A primary limitation of this study is the inability to properly model the U wave in the simulated transmural ECGs and thereby test whether reduced gK1 reproduces QU prolongation and prominent U waves typical of ATS. This limitation is a consequence of our incomplete understanding of the electrophysiological basis of the U wave. Although several theories have been proposed to explain the genesis of the U wave, controversy remains as to its cellular mechanism (13, 18). The mechanoelectrical coupling theory postulates that activation of mechanosensitive (stretch activated) cation channels during ventricular filling generates a small depolarizing current that produces the U wave (13, 18). The molecular identity of a mechanosensitive channel expressed in human heart was recently reported as a member of the transient receptor potential channel (TRPC) family (4). As more experimental evidence becomes available, the properties of mechanosensitive channels will be incorporated into the existing computational modeling framework to test the effects of ATS mutations on cardiac repolarization. Irrespective of our limited understanding of the U wave, any depolarizing influence during phase 4 will be augmented in the setting of reduced gK1, resulting in accentuation of the U wave as typically seen in ATS.

In summary, we propose that the D71V Kir2.1 mutation provides a substrate for arrhythmia by altering the balance between inward and outward currents during phase 4 such that INaCa can trigger the generation of spontaneous action potentials. Our simulations of D71V mutation recapitulate several key ECG features, including QT prolongation, T wave flattening, and QRS widening. Elucidation of the cellular and ionic basis of the U wave will allow simulation of the ECG features typical of ATS, such as prominent U waves and QU prolongation.


    GRANTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This work has been supported by the Richard A. and Nora Eccles Fund for Cardiovascular Research and awards from the Nora Eccles Treadwell Foundation. L. J. Ptácek is an investigator of the Howard Hughes Medical Institute. L. J. Ptácek and M. Tristani-Firouzi are supported by the National Institutes of Health/Rare Disease Clinical Research Network.


    FOOTNOTES
 

Address for reprint requests and other correspondence: F. B. Sachse, Nora Eccles Harrison Cardiovascular Research and Training Institute, Univ. of Utah, Salt Lake City, UT 84108 (e-mail: fs{at}cvrti.utah.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Bendahhou S, Donaldson MR, Plaster NM, Tristani-Firouzi M, Fu YH, Ptácek LJ. Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome. J Biol Chem 278: 51779–51785, 2003.[Abstract/Free Full Text]
  2. Chun TU, Epstein MR, Dick M 2nd, Andelfinger G, Ballester L, Vanoye CG, George AL Jr, and Benson DW. Polymorphic ventricular tachycardia and KCNJ2 mutations. Heart Rhythm 1: 235–241, 2004.[CrossRef][Web of Science][Medline]
  3. Kurata Y, Hisatome I, Matsuda H, Shibamoto T. Dynamical mechanisms of pacemaker generation in IK1-downregulated human ventricular myocytes: insights from bifurcation analyses of a mathematical model. Biophys J 89: 2865–2887, 2005.
  4. Maroto R, Raso A, Wood TG, Kurosky A, Martinac B, Hamill OP. TRPC1 forms the stretch-activated cation channel in vertebrate cells. Nat Cell Biol 7: 179–185, 2005.[CrossRef][Web of Science][Medline]
  5. Miake J, Marban E, Nuss HB. Biological pacemaker created by gene transfer. Nature 419: 132–133, 2002.[Medline]
  6. Miake J, Marban E, Nuss HB. Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression. J Clin Invest 111: 1529–1536, 2003.[CrossRef][Web of Science][Medline]
  7. Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, Donaldson MR, Iannaccone ST, Brunt E, Barohn R, Clark J, Deymeer F, George AL Jr, Fish FA, Hahn A, Nitu A, Ozdemir C, Serdaroglu P, Subramony SH, Wolfe G, Fu YH, and Ptácek LJ. Mutations in Kir21 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105: 511–519, 2001.[CrossRef][Web of Science][Medline]
  8. Preisig-Müller R, Schlichthorl G, Goerge T, Heinen S, Bruggemann A, Rajan S, Derst C, Veh RW, Daut J. Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome. Proc Natl Acad Sci USA 99: 7774–7779, 2002.[Abstract/Free Full Text]
  9. Press WH, Flannery BP, Teukolsky SA, Vetterling WT. Numerical Recipes in C. Cambridge, UK: Cambridge Univ. Press, 1992.
  10. Sanguinetti MC, Tristani-Firouzi M. Delayed and inward rectifier potassium channels. In: Cardiac Electrophysiology From Cell to Bedside (3rd ed.), edited by Zipes DP and Jalife J. Philadelphia, PA: Saunders, Chapt. 9, 2000.
  11. Seemann G, Sachse FB, Weiss DL, Dössel O. Quantitative reconstruction of cardiac electromechanics in human myocardium: regional heterogeneity. J Cardiovasc Electrophysiol 14: S219–228, 2003.[CrossRef][Web of Science][Medline]
  12. Silva J, Rudy Y. Mechanism of pacemaking in IK1-downregulated myocytes. Circ Res 92: 261–263, 2003.[Abstract/Free Full Text]
  13. Surawicz B. U wave: facts, hypotheses, misconceptions, and misnomers. J Cardiovasc Electrophysiol 9: 1117–1128, 1998.[Web of Science][Medline]
  14. ten Tusscher KH, Noble D, Noble PJ, Panfilov AV. A model for human ventricular tissue. Am J Physiol Heart Circ Physiol 286: H1573–H1589, 2004.[Abstract/Free Full Text]
  15. Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A, Bendahhou S, Kwiecinski H, Fidzianska A, Plaster N, Fu YH, Ptácek LJ, Tawil R. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 110: 381–388, 2002.[CrossRef][Web of Science][Medline]
  16. Tsuboi M, Antzelevitch C. Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7). Heart Rhythm 3: 328–335, 2006.[CrossRef][Web of Science][Medline]
  17. Venance SL, Cannon SC, Fialho D, Fontaine B, Hanna MG, Ptácek LJ, Tristani-Firouzi M, Tawil R, Griggs RC. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain 129: 8–17, 2006.[Abstract/Free Full Text]
  18. Viskin S, Zeltser D, Antzelevitch C. When U say "U waves," what do U mean? PACE 27: 145–147, 2004.
  19. Wang Z, Yue L, White M, Pelletier G, Nattel S. Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle. Circulation 98: 2422–2428, 1998.
  20. Weiss DL, Seemann G, Sachse FB, Dössel O. Modelling of short QT syndrome in a heterogeneous model of the human ventricular wall. Europace 7, Suppl 2: 105–117, 2005.[Free Full Text]
  21. Yan GX, Shimizu W, Antzelevitch C. Characteristics and distribution of M cells in arterially perfused canine left ventricular wedge preparations. Circulation 98: 1921–1927, 1998.
  22. Zhang L, Benson DW, Tristani-Firouzi M, Ptácek LJ, Tawil R, Schwartz PJ, George AL, Horie M, Andelfinger G, Snow GL, Fu YH, Ackerman MJ, Vincent GM. Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation 111: 2720–2726, 2005.
  23. Zobel C, Cho HC, Nguyen TT, Pekhletski R, Diaz RJ, Wilson GJ, Backx PH. Molecular dissection of the inward rectifier potassium current (IK1) in rabbit cardiomyocytes: evidence for heteromeric co-assembly of Kir2.1 and Kir2.2. J Physiol 550: 365–372, 2003.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Circ Arrhythm ElectrophysiolHome page
A. L. Vega, D. J. Tester, M. J. Ackerman, and J. C. Makielski
Protein Kinase A-Dependent Biophysical Phenotype for V227F-KCNJ2 Mutation in Catecholaminergic Polymorphic Ventricular Tachycardia
Circ Arrhythm Electrophysiol, October 1, 2009; 2(5): 540 - 547.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Veeraraghavan and S. Poelzing
Mechanisms underlying increased right ventricular conduction sensitivity to flecainide challenge
Cardiovasc Res, March 1, 2008; 77(4): 749 - 756.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Morita, D. P. Zipes, S. T. Morita, and J. Wu
Mechanism of U wave and polymorphic ventricular tachycardia in a canine tissue model of Andersen-Tawil syndrome
Cardiovasc Res, August 1, 2007; 75(3): 510 - 518.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Poelzing and R. Veeraraghavan
Heterogeneous ventricular chamber response to hypokalemia and inward rectifier potassium channel blockade underlies bifurcated T wave in guinea pig
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3043 - H3051.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/H549    most recent
00701.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seemann, G.
Right arrow Articles by Tristani-Firouzi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seemann, G.
Right arrow Articles by Tristani-Firouzi, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.